Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

F-Prime Capital Partners

F-Prime Capital Partners?uq=hBqTzBbB
VC INVESTOR TYPE
Active STATUS
25 PROFESSIONALS
242 INVESTMENTS
114 PORTFOLIO
67 EXITS
Description

F-Prime Capital Partners is a venture capital firm headquartered in Cambridge, Massachusetts. The firm seeks to make investments in firms focused in biopharmaceutical, medtech, healthcare service, enterprise information technology and fintech.

Formerly Known As
Fidelity Biosciences
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Year Founded
1969
Primary Investor Type
Venture Capital
Primary Office
  • 1 Main Street
  • 13th Floor
  • Cambridge, MA 02142
  • United States

+1 (617) 000-0000

F-Prime Capital Partners Investments (242)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Checkmate Pharmaceuticals 12-Dec-2018 Early Stage VC 0000 Biotechnology Generating Revenue 000 0000000
00 0000000000 30-Nov-2018 00000 00000 0000 Hospitals/Inpatient Services Generating Revenue 00000000 000
00000 13-Nov-2018 00000 00000 0000 Financial Software Generating Revenue 00000 00000 00
000000 09-Oct-2018 00000 00000 0000 Information Services (B2C) Generating Revenue
00000 000000000000 01-Oct-2018 00000 00000 0000 Therapeutic Devices Product Development 000 0000000
0000000 0000000000 27-Sep-2018 00000 00000 0000 Biotechnology Product Development 000000 0000 00
0000 0000000 00000 21-Sep-2018 00000 00000 0000 Practice Management (Healthcare) Generating Revenue 0000 00000
0000000000 10-Sep-2018 00000 00000 0000 Other Information Technology Generating Revenue 000000 00000000
Sana Therapeutics 10-Sep-2018 Seed Round 000 Personal Products Generating Revenue 0000000 000000 00
Notable 06-Sep-2018 Early Stage VC 000.00 Medical Records Systems Generating Revenue 0000 00000
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore F-Prime Capital Partners’s full profile, request a free trial.

F-Prime Capital Partners Exits (67)

Company Name Exit Date Exit Type Exit Size Status Buyers
Innovent Biologics 31-Oct-2018 IPO 00000 Completed
  • 4 buyers
0000000 0000000000 31-Oct-2018 000 00000 Completed
000 00000000 14-Sep-2018 000 00000 Completed
00000 (00000000) 26-Apr-2018 000000000000000000 000.00 Completed
  • 0000000000
0000000 00000000 23-Apr-2018 000 00000 Completed
  • 00000000 000000000
000000 00000000000 09-Apr-2018 000000000000000000 00000 Completed
  • 0&0 000000
0000000 0000000000 31-Mar-2018 000000000 00000000 Completed
0000 000000000000 29-Mar-2018 000 000.00 Completed
Acacia Pharma 05-Mar-2018 IPO 000.00 Completed
  • 3 buyers
Tetraphase Pharmaceuticals 01-Mar-2018 Secondary Transaction - Open Market Completed
To view this investor’s complete exits history, request access »

F-Prime Capital Partners Team (57)

Name Title Deals Funds Boards Office Contact
Info
Mary Pendergast Partner & Chief Financial Officer Cambridge, MA
Carl Byers General Partner 00 0 0 Cambridge, MA
Jay Farber Venture Partner Cambridge, MA
John Vigeant Venture Partner Cambridge, MA
Sanjay Aggarwal Venture Partner 0 Cambridge, MA

16 Former Team Members

You’re viewing 5 of 57 team members. Get the full list »

F-Prime Capital Partners Co-Investors (453)

Name With Exits Lead Partner
Eight Roads 30 0 00
OrbiMed 0 0 0
New Enterprise Associates 0 0 0
Venrock 0 0 0
Polaris Partners 0 0
To view this investor’s complete co-investor history, request access »